PVR and lung cancer: A5 Nb significantly inhibited migration and invasion of CD155-overexpressing lung cancer cells at concentrations more than tenfold lower than those required for conventional antibodies, suggesting superior potency and potential for safer dosing strategies (Supplementary Fig. 3, 4).